Skip to main content
رجوع
GENB logo

Generate Biomedicines, Inc.

جودة البيانات: 100%
GENB
NASDAQ Financial Services Asset Management
KWD 12.03
▼ KWD 0.49 (-3.91%)
القيمة السوقية: 1.53B
نطاق اليوم
KWD 11.94 KWD 12.83
نطاق 52 أسبوعًا
KWD 11.00 KWD 15.32
حجم التداول
428,154
متوسط 50 يوم / 200 يوم
KWD 12.26 / KWD 12.26
الإغلاق السابق
KWD 12.52

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Financial Services (854 نظير)

المقياس السهم وسيط القطاع
P/E -7.6 10.3
P/B 1.1
ROE % 11.7
Net Margin % -637.0 16.8
Rev Growth 5Y % 11.7
D/E 0.5

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

النقاط الرئيسية

Negative free cash flow of -204.13M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)55.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-636.99%
Op. Margin-737.04%

الأمان

Debt / Equity
N/A
Current Ratio2.85
Interest Coverage-206.92

التقييم

P/E Ratio
-7.55
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 55.89% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 31.89M Net Income (TTM) -203.15M
ROE N/A ROA -61.53%
Gross Margin 100.00% Operating Margin -737.04%
Net Margin -636.99% Free Cash Flow (TTM) -204.13M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.85
Interest Coverage -206.92 Dividend Yield 0.00%
Valuation
P/E Ratio -7.55 P/B Ratio N/A
P/S Ratio 48.07 PEG Ratio -0.02
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.53B Enterprise Value 1.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024
Revenue 31.89M 20.46M
Net Income -203.15M -173.77M
EPS (Diluted) -4.98 -1.68
Gross Profit 31.89M 20.46M
Operating Income -235.07M -196.94M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024
Total Assets 330.18M 518.26M
Total Liabilities 953.38M 953.35M
Shareholders' Equity -615.97M -434.52M
Total Debt 68.53M 76.97M
Cash & Equivalents 121.65M 176.27M
Current Assets 234.37M 407.49M
Current Liabilities 82.20M 86.63M